Cargando…

Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A

BACKGROUND: The activities of MYC, the androgen receptor, and its associated pioneer factors demonstrate substantial reprogramming between early and advanced prostate cancer. Although previous studies have shown a shift in cellular metabolic requirements associated with prostate cancer progression,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitlock, Nichelle C., White, Margaret E., Capaldo, Brian J., Ku, Anson T., Agarwal, Supreet, Fang, Lei, Wilkinson, Scott, Trostel, Shana Y., Shi, Zhen-Dan, Basuli, Falguni, Wong, Karen, Jagoda, Elaine M., Kelly, Kathleen, Choyke, Peter L., Sowalsky, Adam G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526773/ https://www.ncbi.nlm.nih.gov/pubmed/36181613 http://dx.doi.org/10.1007/s12672-022-00565-3

Ejemplares similares

MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity
por: Whitlock, Nichelle C., et al.
Publicado: (2020)

Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid N-Hydroxysuccinimide Ester (6-[(18)F]SFPy)
por: Basuli, Falguni, et al.
Publicado: (2020)

Fluorine-18 Labeled Fluorofuranylnorprogesterone ([(18)F]FFNP) and Dihydrotestosterone ([(18)F]FDHT) Prepared by “Fluorination on Sep-Pak” Method
por: Basuli, Falguni, et al.
Publicado: (2019)

Fluorine-18 Labeled Urea-Based Ligands Targeting Prostate-Specific Membrane Antigen (PSMA) with Increased Tumor and Decreased Renal Uptake
por: Basuli, Falguni, et al.
Publicado: (2022)

AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification
por: Sowalsky, Adam G., et al.
Publicado: (2020)

Lysine Ethylation by Histone Lysine Methyltransferases
por: Al Temimi, Abbas H. K., et al.
Publicado: (2019)

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
por: Ku, Anson T., et al.
Publicado: (2023)

Synthesis of lysine methyltransferase inhibitors
por: Hui, Chunngai, et al.
Publicado: (2015)

Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers
por: Sharad, Shashwat, et al.
Publicado: (2021)

In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab
por: Roy, Jyoti, et al.
Publicado: (2021)

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer
por: Hennigan, S. Thomas, et al.
Publicado: (2019)

The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
por: Zhou, Xun, et al.
Publicado: (2022)

Chemical Probes of Histone Lysine Methyltransferases
por: Kaniskan, H. Ümit, et al.
Publicado: (2014)

Lysine Possesses the Optimal Chain Length for Histone Lysine Methyltransferase Catalysis
por: Temimi, Abbas H. K. Al, et al.
Publicado: (2017)

Examining sterically demanding lysine analogs for histone lysine methyltransferase catalysis
por: Temimi, Abbas H. K. Al, et al.
Publicado: (2020)

Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer
por: Thng, Dexter Kai Hao, et al.
Publicado: (2023)

Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
por: Binda, Olivier
Publicado: (2019)

Fine-tuning of lysine side chain modulates the activity of histone lysine methyltransferases
por: Al Temimi, Abbas H. K., et al.
Publicado: (2020)

Clinicopathologic significance of protein lysine methyltransferases in cancer
por: Vougiouklakis, Theodore, et al.
Publicado: (2020)

Lysine methyltransferase inhibitors: where we are now
por: Feoli, Alessandra, et al.
Publicado: (2021)

Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models
por: Agarwal, Supreet, et al.
Publicado: (2023)

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)

In vivo Reprogramming of Cancer Metabolism by MYC
por: Camarda, Roman, et al.
Publicado: (2017)

The SET-domain protein superfamily: protein lysine methyltransferases
por: Dillon, Shane C, et al.
Publicado: (2005)

A Chemical Method for Labeling Lysine Methyltransferase Substrates
por: Binda, Olivier, et al.
Publicado: (2011)

Role of several histone lysine methyltransferases in tumor development
por: LI, JIFU, et al.
Publicado: (2016)

The role of histone lysine methyltransferase NSD3 in cancer
por: Han, Xu, et al.
Publicado: (2018)

Structure, Activity, and Function of SETMAR Protein Lysine Methyltransferase
por: Tellier, Michael
Publicado: (2021)

Targets of histone H3 lysine 9 methyltransferases
por: Levinsky, Aidan J., et al.
Publicado: (2022)

Structure, activity and function of the lysine methyltransferase SETD5
por: Li, Mingyang, et al.
Publicado: (2023)

Identification of nonhistone substrates of the lysine methyltransferase PRDM9
por: Hanquier, Jocelyne N., et al.
Publicado: (2023)

The Roles of Histone Lysine Methyltransferases in Heart Development and Disease
por: Zhu, Jun-yi, et al.
Publicado: (2023)

Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
por: Sowalsky, Adam G., et al.
Publicado: (2022)

A proteomic approach for the identification of novel lysine methyltransferase substrates
por: Levy, Dan, et al.
Publicado: (2011)

Genetic alterations of histone lysine methyltransferases and their significance in breast cancer
por: Liu, Lanxin, et al.
Publicado: (2014)

Investigation of the methylation of Numb by the SET8 protein lysine methyltransferase
por: Weirich, Sara, et al.
Publicado: (2015)

The emerging role of lysine methyltransferase SETD8 in human diseases
por: Milite, Ciro, et al.
Publicado: (2016)

Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase
por: Rathert, Philipp
Publicado: (2021)

Effects of the Lysine Methyltransferase Inhibitor AZ505 on Bone Metabolism
por: Song, Min-Kyoung, et al.
Publicado: (2021)

Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s5pmaa9l6rokjgl5q4vv742r38